Trial just started for bone-mestastatic p.cancer in Chicago

http://www.clinicaltrials.gov/ct2/show/NCT01074138

Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy

This study is currently recruiting participants.

Verified by Kinex Pharmaceuticals, LLC, February 2010
First Received: February 22, 2010

Please refer to this study by its ClinicalTrials.gov identifier: NCT01074138


Contacts
Contact: Laura Dalfonso 716-881-7549 [email protected]
Contact: Lyn Dyster, Ph.D. 716-881-8972 [email protected]


Locations
United States, Illinois
University of Chicago Recruiting
Chicago, Illinois, United States, 60637
Contact: Beth Manchen, MS, RN 773-702-4135 [email protected]
Principal Investigator: Edwin Posadas, MD

find more info at: http://www.clinicaltrials.gov/ct2/show/NCT01074138